Sandbox Reserved 1648: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 20: Line 20:
- two CRH domains (a distal membrane homology of the first cytokine receptor '''CHR1''' and a second homology of the cytokine receptor '''CRH2''')
- two CRH domains (a distal membrane homology of the first cytokine receptor '''CHR1''' and a second homology of the cytokine receptor '''CRH2''')


- an immunoglobuline-like domain ('''IGD''')
- an immunoglobuline-like domain ('''<scene name='86/868181/Igd/1'>IGD heavy chain</scene> and <scene name='86/868181/Igd/2'>IGD light chain</scene>''')


- two additional membrane-proximal fibronectin type III ('''<scene name='86/868181/Fn_iii/1'>single FN III domain</scene> or <scene name='86/868181/Fn_iii/2'>Fn III domains</scene>''') domains <ref> DOI:https://doi.org/10.1016/j.str.2012.01.019 </ref> <ref name="refl"> </ref>.
- two additional membrane-proximal fibronectin type III ('''<scene name='86/868181/Fn_iii/1'>single FN III domain</scene> or <scene name='86/868181/Fn_iii/2'>Fn III domains</scene>''') domains <ref> DOI:https://doi.org/10.1016/j.str.2012.01.019 </ref> <ref name="refl"> </ref>.
Line 58: Line 58:
The '''CRH2''' domain is the main leptin binding site on the receptor. This domain is required for the activation of the receptor. It is composed of a region of four consecutive hydrophobic residues. In particular, <scene name='86/868181/Leu_13/1'>Leu13</scene> and <scene name='86/868181/Leu_86/1'>Leu86</scene> of leptin interact with '''<scene name='86/868181/Leu_504/2'>Leu504</scene>''' in CRH2 forming a bond via hydrophobic interactions<ref>Mapping of the interface between leptin and the leptin receptor CRH2 domain : https://jcs.biologists.org/content/118/11/2519 </ref>. In contrast, the receptor functionality is hardly affected when the CRH1 domain is deleted.
The '''CRH2''' domain is the main leptin binding site on the receptor. This domain is required for the activation of the receptor. It is composed of a region of four consecutive hydrophobic residues. In particular, <scene name='86/868181/Leu_13/1'>Leu13</scene> and <scene name='86/868181/Leu_86/1'>Leu86</scene> of leptin interact with '''<scene name='86/868181/Leu_504/2'>Leu504</scene>''' in CRH2 forming a bond via hydrophobic interactions<ref>Mapping of the interface between leptin and the leptin receptor CRH2 domain : https://jcs.biologists.org/content/118/11/2519 </ref>. In contrast, the receptor functionality is hardly affected when the CRH1 domain is deleted.


The '''IGD''' domain has no affinity for leptin but is nevertheless '''required''' for receptor activation. In the absence of this domain, the result is a receptor with a wild-type affinity for leptin. However, the receptor is completely devoid of biological activity.
The '''IGD'''(<scene name='86/868181/Igd/1'>IGD heavy chain</scene> and <scene name='86/868181/Igd/2'>IGD light chain</scene>) domain has no affinity for leptin but is nevertheless '''required''' for receptor activation. In the absence of this domain, the result is a receptor with a wild-type affinity for leptin. However, the receptor is completely devoid of biological activity.


In the '''<scene name='86/868181/Fn_iii/1'>FN III</scene>''' domains, there are two conserved '''cysteines''' ('''Cys-672 and Cys-751''' <ref>Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains : https://www.jbc.org/article/S0021-9258(20)61429-6/fulltext </ref>) that are crucial for the activation of the receptor.  
In the '''<scene name='86/868181/Fn_iii/1'>FN III</scene>''' domains, there are two conserved '''cysteines''' ('''Cys-672 and Cys-751''' <ref>Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains : https://www.jbc.org/article/S0021-9258(20)61429-6/fulltext </ref>) that are crucial for the activation of the receptor.